Related Experiment Video
Updated: Apr 23, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
Organic Cation Transporter-Mediated Clearance of Cardiovascular Drugs: A Pharmacological Perspective
Omar T Hassan1, Reem T Hassan, Rohit R Arora
11Chicago Medical School, North Chicago, IL; and 2College of Pharmacy, North Chicago, IL.
Abstract:
There exist a number of mechanisms to clear xenobiotics from human circulation. For cationic drugs, clearance is performed by human organic cation transporters 1 and 2 (hOCT1 and hOCT2), which are expressed in the liver and kidney, respectively. Given the prevalence of patients taking cardiovascular drugs, the present review focuses on the elimination of circulating cardiovascular drugs by organic cation transporters (OCTs). A significant number of cardiovascular drugs compete for transport by OCT1 or OCT2, introducing the potential to alter the pharmacokinetic profile of other concomitantly administered medications. The OCT system thereby represents an important site of drug-drug interactions.
Insights
Organic cation transporters (OCTs) clear cationic drugs, including many cardiovascular medications, from circulation. These transporters are a key site for drug-drug interactions, potentially altering medication effectiveness.
Area of Science:
- Pharmacology
- Drug Metabolism
- Renal and Hepatic Transport
Background:
- Xenobiotics are cleared from circulation via various mechanisms.
- Cationic drugs are primarily cleared by human organic cation transporters 1 and 2 (hOCT1 and hOCT2).
- hOCT1 is expressed in the liver, and hOCT2 is expressed in the kidney.
Purpose of the Study:
- To review the elimination of circulating cardiovascular drugs by organic cation transporters (OCTs).
- To highlight the role of OCTs in drug-drug interactions involving cardiovascular medications.
Main Methods:
- Literature review focusing on organic cation transporters and cardiovascular drugs.
- Analysis of existing data on drug transport mechanisms and pharmacokinetic interactions.
Main Results:
- A significant number of cardiovascular drugs are substrates for OCT1 or OCT2.
- Competition for OCT1 and OCT2 can alter the pharmacokinetic profiles of co-administered drugs.
- The OCT system is a critical factor in cardiovascular drug interactions.
Conclusions:
- Organic cation transporters play a crucial role in the clearance of cardiovascular drugs.
- Understanding OCT-mediated transport is essential for predicting and managing drug-drug interactions in patients taking cardiovascular medications.
Related Concept Videos
Hepatic Drug Clearance: Role of Transporters
Drug Elimination: The Concept of Clearance
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Pore Transport and Ion-Pair Transport
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Drug Elimination by Renal Route: Tubular Secretion
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Clearance Models: Physiological Models
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...

